Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Buspirone | |
| Synonyms |
|
|
| Definitions |
An anxiolytic agent chemically and pharmacologically unrelated to benzodiazepines, barbiturates, or other sedative/hypnotic drugs. Although its exact mechanism of action is unknown, buspirone may exert its anti-anxiety effects via serotonin (5-HT1A) and dopamine receptors (D2) and may indirectly affect other neurotransmitter systems. Unlike typical benzodiazepine anxiolytics, this agent does not exert anticonvulsant or muscle relaxant effects and lacks prominent sedative effects. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C62013 |
|
| ALT_DEFINITION |
A drug that is used to treat certain anxiety disorders. It belongs to the family of drugs called antianxiety agents.
|
|
| CAS_Registry |
36505-84-7
|
|
| CHEBI_ID |
CHEBI:3223
|
|
| Chemical_Formula |
C21H31N5O2
|
|
| code |
C62013
|
|
| Contributing_Source |
FDA
|
|
| definition |
An anxiolytic agent chemically and pharmacologically unrelated to benzodiazepines, barbiturates, or other sedative/hypnotic drugs. Although its exact mechanism of action is unknown, buspirone may exert its anti-anxiety effects via serotonin (5-HT1A) and dopamine receptors (D2) and may indirectly affect other neurotransmitter systems. Unlike typical benzodiazepine anxiolytics, this agent does not exert anticonvulsant or muscle relaxant effects and lacks prominent sedative effects.
|
|
| FDA_UNII_Code |
TK65WKS8HL
|
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Buspirone
|
|
| Legacy Concept Name |
Buspirone_Base
|
|
| Preferred_Name |
Buspirone
|
|
| prefixIRI |
NCIT:C62013
|
|
| prefLabel |
Buspirone
|
|
| Semantic_Type |
Pharmacologic Substance
|
|
| UMLS_CUI |
C0006462
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping